Regis Resources Limited (ASX: RRL) – RRL Nose-dives on Cost Concerns


Regis Resources Limited (ASX: RRL) Q4 gold production is at 92,008 ounces, up by 8% on Q3; while FY18 production is 361,373 oz which is at the top end of guidance. Throughput, grade & recovery all in line or up on Q3. Q4 stripping ratio has been up from 4.6 to 7.0, and pre-strip of high grade Tooheys Well pit is continuing with Dogbolter and Anchor already commenced, with waste mining at Moolart Well for TSF lifting materials. Q4 cash costs is at $760/oz & AISC is at $982/oz, and AISC stands 8% higher than Q3 due to higher waste volumes, primarily for pre-strips on new pits. The FY18 AISC of $901/oz is below the bottom of guidance range.

Other highlights included record quarterly operating cash flow with Q4 operating cash flow at $85.3m, and continued strong operating cash flow underpinning cash build and dividends. Regis is currently trading at a market price of $4.465 and has seen a daily price change of -$0.535 or a percentage change of -10.7% as at July 31, 2018. Over the past 12 months, the stock has seen a performance change of 30.55%.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report